¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"New Life Vitamin For Hair Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • life table
    »ý¸íÇ¥
  • mean life expectancy
    Æò±Õ¿©¸í
  • mean life span
    Æò±Õ¼ö¸í
  • sylvatic life cycle
    ¾ß»ý»ýȰÁÖ±â
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • beaded hair
    ¿°ÁÖÅÐ, ±¸½½ÅÐ
  • brittle hair syndrome
    Ãë¾à¸ð¹ßÁõÈıº
  • bamboo hair
    ´ë³ª¹«ÅÐ
  • club hair
    °ïºÀÅÐ
  • curly hair
    °ö½½¸Ó¸®
  • cartilage-hair hypoplasia
    ¿¬°ñÅÐÇü¼ºÀúÇÏÁõ
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
  • gustatory hair
    ¹Ì°¢ÅÐ, ¹Ì°¢¸ð
  • hair
    1. ÅÐ 2. ¸ð¹ß, ¸ð 3. ¸Ó¸®ÅÐ
  • hair bezoar
    ¸ð¹ßÀ§¼®, ÅÐÀ§¼®, À§Ã¢ÀÚÅе¢ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • life insurance medicine
    »ý¸íº¸ÇèÀÇÇÐ
  • life insurance method
    »ý¸íº¸Çè¹ý
  • physical half life
    ¹°¸®Àû¹Ý°¨±â
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • mean life span
    Æò±Õ¼ö¸í
  • oral administration
    °æ±¸Åõ¿©
  • oral angle
    ÀÔ²¿¸®
  • oral arch
    (¢¡palatal arch) ÀÔõÀåȰ
  • oral hypoglycemic agent
    °æ±¸Ç÷´ç°­ÇÏÁ¦
  • oral bacteriology
    ±¸°­¼¼±ÕÇÐ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • oral cavity
    ÀÔ¾È, ±¸°­
  • oral cholecystography
    °æ±¸¾µ°³Á¶¿µ¼ú, °æ±¸´ã³¶Á¶¿µ¼ú
  • oral contraception
    °æ±¸ÇÇÀÓ
  • oral contraceptive
    °æ±¸ÇÇÀÓÁ¦, ¸Ô´ÂÇÇÀÓÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Hair receptors
    ¸ð¼ö¿ëü(Ù¾â¥é»ô÷)
  • Inner hair cells
    ³»ÀÌ(Ò®ì¼) À¯¸ð(êóÙ¾)¼¼Æ÷(á¬øà)
  • Kinky hair syndrome
    ŲŰÇì¾îÁõÈıº
  • Menkes (kinky) hair syndrome
    ¸àÄɾûÅ´ÅÐ ÁõÈıº
  • Menkes kinky hair syndrome
    ¸àÄÉŲ۸ðÁõÈıº
  • anagen hair
    ¼ºÀå±â ¸ð¹ß(Ù¾Û¥)
  • fragilitas crinum = brittleness of hair<³ª>
    ¸ðÃë¾àÁõ(Ù¾öªå°ñø)
  • gray hair
    ¹é¸ð
  • gustatory hair
    ¹Ì¸ð(Ú«Ù¾).
  • gustatory hair
    ¹Ì¸ð(Ú«Ù¾)
  • hair
    ÅÐ
  • hair bezoar =trichobezoar
    ¸ð(¹ß)À§¼®(Ù¾ êÖà´).
  • hair bud
    ¸ð¾Æ,ÅнÏ
  • hair bud
    ÅнÏ
  • hair canal
    ÅÐÁָӴϰü, ¸ð°ü(پη).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • effective half-life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • embryonic life
    ¹èÅ»ýȰ(ÛÏ÷ÃßæüÀ).
  • expectancy of life
    ¿©¸í(ËçËÎ).
  • expectation of life
    ¿©¸í.
  • half-life
    ¹Ý°¨±â
  • intrauterine life
    Àڱó»»ýȰ(¡­ßæüÀ).
  • life annuity
    Á¾½Å¿¬±Ý(Ì¡ËàËçË»).
  • life change scale
    »ýȰº¯È­Ã´µµ(~ô©Óø)
  • life cycle
    »ýȰÁÖ±â
  • life cycle
    »ýȰÁÖ±â(~ñÎÑ¢)
  • life cycle
    »ýȰ»ç, »ýȰÁÖ±â, »ýȰȯ
  • life expectancy
    ¼ö¸í.
  • life form
    »ýȰÇü(Ë×Ì·Ì´).
  • life habit
    »ýȰ½À¼º(ÊÙËàËÛ), »ýȰ½À°ü (ÊÙËàË´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Hair bud
    ÅнÏ
    [¿¾ ¿ë¾î] ¸ð·Ú
  • Hair papilla
    ÅÐÀ¯µÎ
    [¿¾ ¿ë¾î] ¸ðÀ¯µÎ
  • Capillary network of hair papilla
    ÅÐÀ¯µÎ¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ¸ðÀ¯µÎ¸ð¼¼Ç÷°ü¸Á
  • Hair follicle
    ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ¸ð³¶
  • Canal of hair follicle
    ÅÐÁָӴϰü
    [¿¾ ¿ë¾î] ¸ð³¶°ü
  • Neck of hair follicle
    ÅÐÁָӴϸñ
    [¿¾ ¿ë¾î] ¸ð³¶°æ
  • Base of hair follicle
    ÅÐÁָӴϹٴÚ
    [¿¾ ¿ë¾î] ¸ð³¶Àú
  • Lanceolate terminal of hair follicle
    ÅÐÁÖ¸Ó´ÏÁ¾¸»
    [¿¾ ¿ë¾î] ¸ð³¶Á¾¸»
  • Sinus of hair follicle
    ÅÐÁÖ¸Ó´ÏÇ÷°üµ¿±¼
    [¿¾ ¿ë¾î] ¸ð³¶¸ð¼¼Ç÷°ü¸Á
  • Hair shaft
    ÅÐÁÙ±â
    [¿¾ ¿ë¾î] ¸ð°£
  • Shaft of hair
    ÅÐÁÙ±â
    [¿¾ ¿ë¾î] ¸ð°£
  • Dermal sheath of hair
    ÅÐÁøÇÇÁý
    [¿¾ ¿ë¾î] ¸ðÁøÇÇÃÊ
  • Hair stream
    ÅÐÈ帧
    [¿¾ ¿ë¾î] ¸ð·ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vitamin B12
    ºñŸ¹Î B12
  • vitamin B complex
    ºñŸ¹Î B º¹ÇÕü (ÜÜùêô÷)
  • Vitamin B group
    ºñŸ¹Î B ±º(ÏØ)
  • vitamin C
    ºñŸ¹Î C
  • vitamin D
    ºñŸ¹Î D
  • vitamin D1
    ºñŸ¹Î D1
  • vitamin D2
    ºñŸ¹Î D2
  • vitamin D3
    ºñŸ¹Î D3
  • vitamin D-resistant rickets
    ºñŸ¹Î D ÀúÇ×¼º(î½ù÷àõ) ±¸·çº´(±¸·çÜ»)
  • vitamin E
    ºñŸ¹Î E
  • vitamin F
    ºñŸ¹Î F
  • vitamin G
    ºñŸ¹Î G
  • vitamin H
    ºñŸ¹Î H
  • vitamin hypothesis
    ºñŸ¹Î ¼³(àã)
  • vitamin K
    ºñŸ¹Î K
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PIVKA protein induced by vitamin K absence or antagonism
UBBC unsaturated vitamin B12 binding capacity
VAD venous access device; ventricular assist device; vinblastine and dexamethasone; vitamin A deficiency...
VDD atrial synchronous ventricular inhibited [pacemaker]; vitamin D-dependent
VDDR vitamin D-dependent rickets
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NACI New Approaches to Coronary Intervention
NDA New Drug Application
NEJM New England Journal of Medicine
NSW New South Wales
NY New York
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vitamin B2 deficiency
    ºñŸ¹Î B2 °áÇÌÁõ
  • vitamin C
    ºñŸ¹Î C
    ¾Æ½ºÄݺó»ê. Ç×±«Ç÷Áõ ÀÛ¿ëÀ» ÇÑ´Ù. ¿­¿¡ ¾àÇÏ°í °­·ÂÇÑ È¯¿ø ÀÛ¿ëÀÌ ÀÖ¾î, ¿©·¯ È¿¼ÒÀÇ ÀÛ¿ë ¹ßÇö¿¡ ÀÖ¾î Àû´çÇÑ »êȭȯ¿ø »óÅÂÀÇ À¯Áö¿¡ µµ¿òÀÌ µÇ¸ç, ¼ö¼Ò¿î¹Ýü·Î¼­ ÀÛ¿ëÇϰí ÀÖ´Ù. »êÈ­´Â ºû, ¾ËÄ®¸®, ö, ±¸¸®¿¡ ÀÇÇÏ¿© ÃËÁøµÈ´Ù. ½ºÅ×·ÎÀÌµå »ýÇÕ¼º ¶§ÀÇ ¼ö»êÈ­¿¡µµ ¾Æ½ºÄÚ¸£ºó »êÀÌ °ü¿©ÇÑ´Ù.
  • vitamin compound
    ºñŸ¹Î º¹ÇÕÁ¦
    ºñŸ¹ÎÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿µ¾çÁ¦·Î¼­ ºñŸ¹Î °áÇÌÁõÀÇ Ä¡·á¿Í ¿¹¹æ¿¡ »ç¿ëµÇ´Â ÀǾàǰ. ÇöÀç ºñŸ¹Î B2¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ ºñŸ¹ÎµéÀº ÇÕ¼ºÇÒ ¼ö ÀÖ°í È­Çлê¾÷¿¡ ÀÇÇØ ´Ù·®À¸·Î Á¦Á¶°¡ °¡´ÉÇϹǷΠ´ëºÎºÐÀÇ ºñŸ¹ÎÁ¦´Â ÇÕ¼ºÇ°À¸·Î ¸¸µé¾îÁø´Ù. ´ÜÀÏ Á¦Á¦ Áß¿¡ ÇÑ Á¾·ùÀÇ ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç ´ÜÀÏ ºñŸ¹ÎÁ¦, Áö¿ë¼º ÈæÀº ¼ö¿ë¼º ºñŸ¹Î ¸î Á¾·ù¸¸À» º¹ÇÕ½ÃÄÑ ¸¸µç º¹ÇÕ ºñŸ¹ÎÁ¦, °ÅÀÇ ¸ðµç ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç Á¾ÇÕ ºñŸ¹ÎÁ¦°¡ ÀÖ¾î ¿ëµµ¿¡ µû¶ó »ç¿ëµÈ´Ù. ºñŸ¹ÎÁ¦´Â Áúº´, ¾Ë·¹¸£±â, ½Ä»çÀÇ Á¦ÇÑ µî ¾î¶² ÀÌÀ¯¿¡¼­ ÀûÀýÇÑ ½Ä»ç¸¦ ÇÏÁö ¸øÇÏ´Â »ç¶÷¿¡°Ô´Â ¸Å¿ì À¯¿ëÇϳª Á¤±Ô½Ä»ç¸¦ ÇÏ´Â °Ç°­ÇÑ »ç¶÷ÀÌ ºñŸ¹ÎÀ» ´õ º¸Ãæ¼·ÃëÇϱâ À§ÇÏ¿© »ç¿ëÇÏ´Â °ÍÀº ³¶ºñÀ̰ųª ÇØ°¡ µÇ´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î »ï°¡¾ß ÇÑ´Ù. 5°¡Áö ±âÃʽÄǰ±º¿¡ ±âº»À» µÐ ±ÕÇü½Ä»ç´Â ¸öÀÌ ÇÊ¿ä·Î ÇÏ´Â ¸ðµç ºñŸ¹ÎÀ» °ø±ÞÇϱ⿡ ÃæºÐÇϸç, Çʿ䷮ ÀÌ»óÀÇ ºñŸ¹ÎÀÌ °Ç°­¿¡ ÇØ·Ó±â ¶§¹®ÀÌ´Ù. Á¤±Ô½Ä»ç¸¦ ÅëÇÑ ºñŸ¹ÎÀÇ ¼·Ãë´Â °áÄÚ °úÀ× µ¶¼º¼öÁرîÁö °¡Áö ¾ÊÁö¸¸, ³óÃàµÈ ºñŸ¹ÎÁ¦¸¦ °è¼Ó ¸ÔÀ¸¸é °úÀ× µ¶¼º ¼öÁرîÁö À̸£°Ô µÈ´Ù. ½Ä»ç¸¦ ÅëÇÏ¿© °Ç°­À¯Áö¿Í Áúº´¿¹¹æ¿¡ ÇÊ¿äÇÑ ¸ðµç ºñŸ¹ÎÀ» ¼·ÃëÇØ¾ß ÇÑ´Ù.
  • vitamin D
    ºñŸ¹ÎD
    ºñŸ¹ÎÀÇ ÇѰ¡Áö. Ç÷¾× ¼ÓÀÇ Ä®½·À» Á¶ÀýÇÏ¸ç °áÇÌµÇ¸é ±¸·çº´ÀÌ µÊ. °£À¯, ´Þ°¿ ³ë¸¥ÀÚ µûÀ§¿¡ µé¾î ÀÖÀ½.
  • vitamin D deficiency
    ºñŸ¹Î D °áÇÌ, ºñŸ¹Î D °áÇÌÁõ
    ±¸·çº´-°ñ¿¬È­ÁõÀ¸·Î µî»À³ª °¡½¿»À µûÀ§°¡ ±Á´Â º´. °ö»çº´.
  • vitamin D dependency
    ºñŸ¹Î D ÀÇÁ¸¼º
  • vitamin D milk
    ºñŸ¹ÎD ¿ìÀ¯
  • vitamin D resistant osteomalacia
    ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­, ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­Áõ
  • vitamin deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
    ¸é Á¾·ùÀÇ ½ÄǰÀ» ¼¯Àº º¸ÅëÀÇ ½Ä»ç¸¦ º¸Åë Á¶¸®¹ý¿¡ µû¶ó ¸ÔÀ» °æ¿ì´Â ºñŸ¹Î °áÇÌÁõÀÌ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ±×·¯³ª ¿¹¿Ü·Î½á ºñŸ¹Î D°áÇÌÁõÀº ÀÚÁÖ ³ªÅ¸³­´Ù. ½Äǰ Áß¿¡´Â ¿©·¯ Á¾·ùÀÇ ºñŸ¹ÎÀÌ °øÁ¸Çϰí Àֱ⠶§¹®¿¡ 1 Á¾·ù¸¸ÀÇ ºñŸ¹Î °áÇÌÁõº¸´Ùµµ ¿©·¯ Á¾·ùÀÇ ºñŸ¹Î °áÇÌÁõÀÌ ¸¹´Ù. ¼ÒÈ­±â Áúȯ¿¡ ¼ö¹ÝµÇ´Â Èí¼öÀå¾Ö, °¢Á¾ ¾àÀçÀÇ º¹¿ë¿¡ ÀÇÇÑ Àå³» ¼¼±ÕÃþÀÇ º¯È­, ü³»¿¡¼­ÀÇ ºñŸ¹Î Ȱ¼ºÈ­ÀÇ ÀúÇØ, »ý¸®Àû º¯È­¿¡ ´ëÀÀÇÑ ¿ä±¸·®ÀÇ Áõ°¡, °¨¿° µî¿¡ ÀÇÇØ °áÇÌÁõÀÌ ¹ß°ßµÇ´Â °æ¿ì°¡ ÀÖ´Ù. ±×·¯³ª ¾àÇÑ Á¤µµÀÇ °áÇÌÀÎ °æ¿ì¿¡´Â ÀüÇüÀû Áõ»óÀº º¸ÀÌÁö ¾ÊÀ¸¸ç, ÀÌ ¶§ÀÇ Áõ»óÀ» ºñŸ¹Î °¨¼ÒÁõÀ̶ó°í ÇÑ´Ù.
  • vitamin deficiency symptom
    ºñŸ¹Î °áÇÌÁõ
    ºñŸ¹ÎÀÇ ºÎÁ·À¸·Î ÀϾ´Â »ý¸® ±â´É Àå¾Ö. ¾ß¸ÍÁõ, °¢±âº´ µûÀ§°¡ ÀÖ´Ù.
  • vitamin E
    ºñŸ¹ÎE
    ºñŸ¹ÎÀÇ ÇÑ °¡Áö. °áÇÌµÇ¸é ºÒÀÓ, À¯»ê µîÀ» ÀÏÀ¸Å´.
  • vitamin I deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
  • vitamin K deficiency
    ºñŸ¹Î K °áÇÌ, ºñŸ¹Î K °áÇÌÁõ
    Ç÷¾×ÀÇ ÀÀ°í ½Ã°£ÀÌ ±æ¾îÁø´Ù.
  • water soluble vitamin
    ¼ö¿ë¼º ºñŸ¹Î
    ¹°¿¡ ³ì´Â ºñŸ¹Î. ºñŸ¹Î B, C.
  • abridged life table
    °£ÀÌ »ý¸íÇ¥
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
wrongful life In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.
(12 Dec 1998)
postnatal life That interval of life after birth; in man, usually divided into periods: neonatal, infancy, childhood, adolescence, and adulthood.
(05 Mar 2000)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
prenatal life That interval of life between conception and birth; in humans, usually divided into embryonic and foetal periods.
(05 Mar 2000)
sexual life In psychiatry and psychoanalysis, the specifically erotic or sexual interests, fantasies, inclinations, and conduct of the patient.
(05 Mar 2000)
direct life cycle <epidemiology> A life cycle in which a parasite is transmitted directly from one host to the next without an intermediate host or vector of another species.
(05 Dec 1998)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
immediately dangerous to life concentration <radiobiology> This is a regulatory value defined as the maximum exposure concentration in the workplace from which one could escape within 30 minutes without suffering symptoms which would interfere with escaping and without suffering any irreversible health effects.
(04 Nov 1997)
quality adjusted life year A year of life adjusted for its quality or its value. A year in perfect health is considered equal to 1.0 qaly. The value of a year in ill health would be discounted. For example, a year bedridden might have a value equal to 0.5 qaly.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services.
(12 Jul 2000)
quality of life Refers to the level of comfort, enjoyment, ability to pursue daily activities. Often used in discussions of treatment options.
(16 Dec 1997)
indirect life cycle <epidemiology> A life cycle which requires one or more intermediate hosts before the definitive host species is reinfected. Compare direct, nondirect.
(05 Dec 1998)
insurance, life Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.
(12 Dec 1998)
economic value of life The evaluation of the monetary value of a life lost or a life saved.
(12 Dec 1998)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hair space
    Çì¾î ½ºÆäÀ̽º(¾î°£ÀÇ ÃÖ¼Ò °£°Ý,ÃÖ¼Ò °£°ÝÀÇ È°ÀÚ)
  • hair spray
    Çì¾î ½ºÇÁ·¹ÀÌ
  • hair stroke
    (±Û¾¾ÀÇ)°¡´Â ¼±;(±Û¾¾ÀÇ Àå½Ä¿¡ ¾²´Â)°¡´Â¼±(serif)
  • hair stylist
    (¿©¼ºÀÇ »õ·Î¿î ¸Ó¸® ÇüÀ» ¿¬±¸ÇÏ´Â)¹Ì¿ë»ç(=hairdresser)
  • hair transplant
    ¸ð¹ß À̽Ä(¼ú,¹ý)(´ë¸Ó¸® ºÎºÐ¿¡ Àڱ⠸ð¹ßÀ» À̽ÄÇÏ´Â)
  • hair trigger
    (±ÇÃÑÀÇ)ÃË¹ß ¹æ¾Æ¼è
  • hair trigger
    (ÃÑÀÇ)ÃË¹ß ¹æ¾Æ¼è;¹Î°¨ÇÑ ±â±¸(¹ÝÀÀ
  • hair'sbreadth
    =HAIRBREADTH
  • root hair
    »Ñ¸®ÅÐ;±Ù¸ð
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
  • half life
    ¹Ý°¨±â
  • life
    »ý¸í,ÀÏ»ý,Àλý,»ýȰ
  • life-giving
    »ý¸íÀ» ÁÖ´Â
  • life-size
    ½Ç¹° Å©±âÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á